After a global search, Adaptimmune has found its next CEO at home: Chief Financial Officer Adrian Rawcliffe will take over in September when CEO and co-founder James Noble retires. The T-cell therapy specialist is now on the hunt for a new CFO. Source: Fierce Biotech 25/6/2019